Jurgens Maya, Sidhu Tarandeep, Jamali Amir A
Department of Orthopedic Surgery, Joint Preservation Institute, Walnut Creek, CA, USA.
Orthop Res Rev. 2025 Aug 23;17:413-420. doi: 10.2147/ORR.S525289. eCollection 2025.
Ultrasound guided hip injections have played a major role in the in-office diagnosis and treatment of a variety of traumatic and degenerative hip joint conditions. There is limited information as to the onset and duration of relief from these types of injections using a uniform medication combination.
HYPOTHESIS/PURPOSE: The purpose of the study is to evaluate the clinical characteristics of a population of patients undergoing ultrasound guided hip corticosteroid injections. We hypothesized that these injections have a low complication rate and a high degree of pain relief for patients.
Case Series.
We performed a retrospective study on 117 first time hip intraarticular injections performed by one operator using a single ultrasound machine and using the identical technique. In all cases, the hip joint was injected with 4 mL of 1% lidocaine and triamcinolone 40mg. The preinjection pain score was available in 98 hips with a mean of 6.4 ± 1.9 (mean ± S.D).
96% of patients had immediate improvement of pain (113/117). There were more right than left hips (67 vs 50) and more females than males (63 vs 54). The most common underlying diagnosis was osteoarthritis (53%). The relief duration was less than 3 months for most patients but longer than 6 months in 4 patients. Adverse outcomes were minimal with no infections and one allergic reaction.
This series represents the largest series of first time hip intraarticular injections with lidocaine and triamcinolone. This regimen has a high probability of immediate pain relief and low complications based on this series of patients.
超声引导下的髋关节注射在多种创伤性和退行性髋关节疾病的门诊诊断和治疗中发挥了重要作用。关于使用统一药物组合进行这类注射后疼痛缓解的起效时间和持续时间的信息有限。
假设/目的:本研究的目的是评估接受超声引导下髋关节皮质类固醇注射的患者群体的临床特征。我们假设这些注射对患者的并发症发生率低且疼痛缓解程度高。
病例系列。
我们对一名操作者使用一台超声机并采用相同技术进行的117例首次髋关节关节内注射进行了回顾性研究。在所有病例中,向髋关节注射4毫升1%利多卡因和40毫克曲安奈德。98例髋关节有注射前疼痛评分,平均为6.4±1.9(均值±标准差)。
96%的患者疼痛立即改善(113/117)。右侧髋关节比左侧多(67例对50例),女性比男性多(63例对54例)。最常见的潜在诊断是骨关节炎(53%)。大多数患者的缓解持续时间少于3个月,但有4例患者超过6个月。不良后果极少,无感染,仅有1例过敏反应。
本系列代表了最大规模的首次使用利多卡因和曲安奈德进行髋关节关节内注射的病例系列。基于这组患者,该治疗方案有很高的立即缓解疼痛的可能性且并发症少。